BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Search i

Search help

  • Enter one or more search terms in the search field. Upper and lower case are not relevant.
  • As soon as you have entered three letters in the search field, various search words will be suggested from which you can choose one.
  • If you are searching for a certain group of words, put these words in double quotes. The hits will then contain the words in the order you entered, e.g. "medicines for children".
  • Multiple search terms can also be combined with the Boolean operators AND and OR. When using the operator AND, the results contain the intersection of all search terms. When using the operator OR, the hits contain one of the search terms or only individual search terms. The result set is therefore significantly larger. Please note that these operators must be written in capital letters.
  • If you receive a (too) large number of hits as a result of your search, you can narrow it down by using filters. These filter options appear to the left of the search results and are subdivided into:

    • category (e.g. safety of medicinal products, medical devices, code systems)
    • format (e.g. download, risk information, DHPCs)
    • time interval (e.g. last 30 days, older than ...)
  • Selected filters can be removed individually or all at once ("Show all results").
  • By default, search results are sorted by relevance, but they can also be sorted chronologically ("Latest entries first" or "Oldest entries first").

Enter search term

819 results

Results per page: 10 20 30

Rote-Hand-Brief on Protelos® PDF, 2MB, File is accessible Date: 04. April 2012 Topics: Pharmakovigilanz Type: Download

Active substance: strontium ranelate

Information Letter on Viaspan® PDF, 113KB, File is accessible Date: 04. April 2012 Topics: Pharmakovigilanz Type: Download

Organ preservation solution

Information Letter on Pegasys® PDF, 800KB, File is accessible Date: 04. April 2012 Topics: Pharmakovigilanz Type: Download

Active substance: pegylated interferon alfa 2a

Dear Doctor Letter (Rote-Hand-Brief) on Protelos® (strontium ranelate): New contraindications PDF, 2MB, File is accessible Date: 04. April 2012 Topics: Pharmakovigilanz Type: Direct Healthcare Professional Communication

Active substance: strontium ranelate

The pharmaceutical entrepreneur is sending out information on new contraindications and warnings for the use of Protelos® (strontium ranelate). These changes also apply to Osseor®.

Information Letter on Pegasys® (pegylated interferon alfa 2a) pre-filled syringes: Possible shortage PDF, 800KB, File is accessible Date: 04. April 2012 Topics: Pharmakovigilanz Type: Direct Healthcare Professional Communication

Active substance: pegylated interferon alfa 2a

Possible shortage of the pharmaceutical form Pegasys® pre-filled syringes and recommendations for healthcare professionals. Prefilled pens are not affected.

Information Letter on Viaspan® (organ preservation solution): Possible contamination of product during the manufacture PDF, 113KB, File is accessible Date: 04. April 2012 Topics: Pharmakovigilanz Type: Direct Healthcare Professional Communication

Active substance: organ preservation solution

Since alternative products are licensed in Germany, all potentially contaminated batches of ViaSpan® are recalled in Germany as a precautionary measure. Close medical monitoring after transplantation is recommended for affected patients by way …

Pioglitazone (Actos®, Competact®, Tandemact®): Guide for prescription and risk management Date: 30. March 2012 Topics: Pharmakovigilanz Type: Risk information

Active substance: pioglitazone

The company Takeda Pharma has published the "Pioglitazone Prescriber's Guide: Patient Selection and Risk Minimisation" thus implementing a further risk minimisation measure from the corresponding decision of the EU Commission.

Rote-Hand-Brief on Samsca® PDF, 585KB, File is accessible Date: 27. March 2012 Topics: Pharmakovigilanz Type: Download

Active substance: tolvaptan

Rote-Hand-Brief on Perfalgan® PDF, 387KB, File is accessible Date: 27. March 2012 Topics: Pharmakovigilanz Type: Download

Active substance: paracetamol i.v.

Dear Doctor Letter (Rote-Hand-Brief) on Perfalgan® 10 mg/ml solution for infusion (paracetamol i.v.): Risk of accidental overdosage PDF, 387KB, File is accessible Date: 27. March 2012 Topics: Pharmakovigilanz Type: Direct Healthcare Professional Communication

Active substance: paracetamol i.v.

The pharmaceutical manufacturer again refers to the risk of an accidental overdosage of Perfalgan® 10 mg/ml solution for infusion in neonates and infants as well as in underweight adults.